Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC
Several professional societies have developed evidence-based guidelines on the use of certain biomarkers to help determine which patients with non–small cell lung carcinoma (NSCLC) may benefit from im…